NFA
BIIB icon

Northwest Financial Advisors’s Biogen BIIB Stock Holding History

Northwest Financial Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-9
Closed -$1.75K – 156
2024
Q3 		$1.75K Buy
+9
New +$1.88K ﹤0.01% 503
2024
Q1 		– Sell
-9
Closed -$2.33K – 134
2023
Q4 		$2.33K Buy
+9
New +$2.21K ﹤0.01% 485

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Northwest Financial Advisors's BIIB Position: Q4 2024 in Review

Northwest Financial Advisors sold out of Biogen (BIIB) in Q4 2024, closing a stake of 9 shares — an estimated $1.75K sold.

Northwest Financial Advisors first reported a position in BIIB in Q4 2023 and held it in 2 quarters. The position peaked at $2.33K in Q4 2023. 876 funds tracked by Wall St. Rank hold BIIB as of Q4 2024.

  • Northwest Financial Advisors reported no remaining Biogen position as of Q4 2024 after selling out during the quarter.
  • Northwest Financial Advisors sold 9 Biogen shares in Q4 2024, an estimated $1.75K.
  • Northwest Financial Advisors first reported a position in Biogen in Q4 2023 and held it in 2 quarters.
  • Northwest Financial Advisors's Biogen position peaked at $2.33K in Q4 2023.
  • 876 funds tracked by Wall St. Rank held Biogen as of Q4 2024.

Based on Northwest Financial Advisors's 13F filing for Q4 2024, filed 22 Jan 2025.